Biogen

BioNTech US Inc, based in Cambridge, MA, is a pioneering global immunotherapy company that focuses on developing innovative treatments aimed at combatting cancer, infectious diseases, and other serious health conditions. With its origins in Mainz, Germany, the company leverages a robust international network and a strong commitment to research and development to advance next-generation immunotherapies. Driven by scientific rigor and operational excellence, BioNTech is dedicated to unlocking the full potential of the immune system and enhancing the health of individuals worldwide. The company continually expands its global manufacturing capabilities to ensure equitable access to its innovative therapies. Generated from the website

Aastrom Biosciences develops products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell adult stem cell technology. Aastrom's TRC products contain large numbers of stromal, stem and progenitor cells that are produced from a small amount of bone marrow cells originating from patients. Its patented AastromReplicell system, an industry-unique automated cell product manufacturing platform, was developed for the production of standardized, patient-specific TRC products. TRC products have been used safely in humans as a substitute for bone marrow stem cells and are currently in clinical trials for bone grafting and blood vessel regeneration applications. Aastrom Biosciences is located in Ann Arbor, Mich., and trades on the NASDAQ under the symbol ASTM.

Cellmig Biolabs is a global leading biopharmaceutical company based in Cambridge, MA, dedicated to developing next-generation medicines and medical devices for the diagnosis and treatment of tumor metastasis and cancers. Their fearless and integrative teams are committed to translating revolutionary discoveries into pioneering molecules and biomedicines that aim to save lives and improve the quality of life for cancer patients worldwide. With a focus on early-stage diagnosis and therapy, Cellmig Biolabs is at the forefront of creating novel solutions for terminating cancer lethality. Their groundbreaking research and development efforts are driven by a team of talented professionals, including researchers, scientists, and specialists, who are dedicated to making a significant impact in the field of cancer treatment and care.Generated from the website